Topic: Ways To Well

Brigham Bueller, founder of Ways to Well and a former pharmaceutical representative at Eli Lilly, provides testimony on the systemic corruption within the medical industry. Bueller argues that the healthcare system is not broken but intentionally rigged to monetize chronic disease rather than curing it. His experience spans surgical med-tech and entrepreneurship, leading to his current role as a whistleblower against the collusion between Big Pharma and insurance conglomerates.

The rise in the childhood vaccine schedule from 10 doses in 1984 to over 70 today is linked to a dramatic increase in autism rates, now at 1 in 36 children. The discussion also targets the head of the Biden administration's Scientific Integrity Committee, alleging she was previously sanctioned for misrepresenting global warming data. Brigham Bueller provides resources and documentation for these claims on the Ways to Well blog.

Insurance companies in Texas and across the U.S. frequently block primary care physicians from ordering comprehensive blood work or non-addictive pain treatments. This interference contributes to a projected shortage of primary care doctors, as many consider exiting the profession due to administrative constraints. The current healthcare system is compared to a "front row seat on the Titanic," where insurance only covers catastrophic "wrecks" rather than preventative maintenance.

Ways to Well utilizes advanced diagnostic tools such as DEXA scans, VO2 Max testing, and pharmacogenetic screenings to assess patient health at the biological level. These tests allow clinicians to identify risks for heart attack and stroke decades before symptoms manifest. Pharmacogenetic testing specifically identifies how a patient's genome metabolizes drugs, revealing that a significant percentage of the population cannot effectively absorb certain medications like opioids.

Ways to Well focuses on "optimal" health rather than the "normal" ranges defined by a chronically ill American population. By assessing 70+ biomarkers outside of the insurance framework, the company provides 45-minute consultations to empower patients to manage their own longevity. This model allows for deep dives into genetics and biology that are typically denied by insurance companies, which only cover care once a patient is already sick.